Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2018 | Limitations with AI programs for prescription screening

Bruce Burnett • 12 Oct 2018

While artificial intelligence (AI) has revolutionized healthcare by minimizing the element of human error, thus improving efficiency, limitations do still exist. In this video, Bruce Burnett, MMedSci, of the University of Central Lancashire, Preston, UK, discusses the limitations of utilizing AI programs for prescription screening. This interview was recorded at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK.